{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T22:46:58Z","timestamp":1692053218733},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T00:00:00Z","timestamp":1363132800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s11096-013-9763-2","type":"journal-article","created":{"date-parts":[[2013,3,12]],"date-time":"2013-03-12T01:36:36Z","timestamp":1363052196000},"page":"316-318","source":"Crossref","is-referenced-by-count":10,"title":["Unusual drug reaction between valproate sodium and meropenem"],"prefix":"10.1007","volume":"35","author":[{"given":"Hyonok","family":"Yoon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana H.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,13]]},"reference":[{"issue":"1","key":"9763_CR1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0301-0082(98)00075-6","volume":"58","author":"W Loscher","year":"1999","unstructured":"Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol. 1999;58(1):31\u201359.","journal-title":"Prog Neurobiol"},{"issue":"3","key":"9763_CR2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/j.1875-9114.1985.tb03413.x","volume":"5","author":"EM Rimmer","year":"1985","unstructured":"Rimmer EM, Richens A. An update on sodium valproate. Pharmacotherapy. 1985;5(3):171\u201384.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"9763_CR3","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","volume":"39","author":"H Mori","year":"2007","unstructured":"Mori H, Takahashi K, Mizutani T. Interaction between valproic acid and carbapenem antibiotics. Drug Metab Rev. 2007;39(4):647\u201357.","journal-title":"Drug Metab Rev"},{"issue":"6","key":"9763_CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1211\/0022357011776171","volume":"53","author":"M Torii","year":"2001","unstructured":"Torii M, Takiguchi Y, Saito F, Izumi M, Yokota M. Inhibition by carbapenem antibiotic imipenem of intestinal absorption of valproic acid in rats. J Pharm Pharmacol. 2001;53(6):823\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"9763_CR5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1002\/jps.20338","volume":"94","author":"K Omoda","year":"2005","unstructured":"Omoda K, Murakami T, Yumoto R, Nagai J, Maeda Y, Kiribayashi Y, et al. Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human. J Pharm Sci. 2005;94(8):1685\u201393.","journal-title":"J Pharm Sci"},{"issue":"9","key":"9763_CR6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1023\/A:1013046229699","volume":"18","author":"K Yokogawa","year":"2001","unstructured":"Yokogawa K, Iwashita S, Kubota A, Sasaki Y, Ishizaki J, Kawahara M, et al. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits. Pharm Res. 2001;18(9):1320\u20136.","journal-title":"Pharm Res"},{"issue":"4","key":"9763_CR7","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/187231208786734049","volume":"2","author":"Y Nakamura","year":"2008","unstructured":"Nakamura Y, Nakahira K, Mizutani T. Decreased valproate level caused by VPA-glucuronidase inhibition by carbapenem antibiotics. Drug Metab Lett. 2008;2(4):280\u20135.","journal-title":"Drug Metab Lett"},{"issue":"1","key":"9763_CR8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.medcli.2010.06.026","volume":"137","author":"MI Fernandez Garcia","year":"2011","unstructured":"Fernandez Garcia MI, de la Puebla Fernandez, Gimenez RA, Garcia Olid B, Torres Degayon V. Meropenem decreases valproate plasmatic concentrations. Med Clin (Barc). 2011;137(1):43\u20134.","journal-title":"Med Clin (Barc)"},{"issue":"3","key":"9763_CR9","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pediatrneurol.2004.03.014","volume":"31","author":"E Nacarkucuk","year":"2004","unstructured":"Nacarkucuk E, Saglam H, Okan M. Meropenem decreases serum level of valproic acid. Pediatr Neurol. 2004;31(3):232\u20134.","journal-title":"Pediatr Neurol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9763-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-013-9763-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-013-9763-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T01:54:41Z","timestamp":1559354081000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-013-9763-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,13]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9763"],"URL":"https:\/\/doi.org\/10.1007\/s11096-013-9763-2","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,13]]}}}